Introduction
Alzheimer's disease (AD) is the most common cause of dementia in the elderly with a worldwide prevalence estimated to quadruple over the next 50 years. AD is pathologically characterized by the presence of amyloid plaques, containing amyloid-beta (Aβ), and neurofibrillary tangles, containing hyperphosphorylated tau, as well as significant loss of neurons and deficits in neurotransmitter systems. A growing consensus points to deposition of Aβ plaques as a central event in the pathogenesis of AD. This "amyloid cascade hypothesis" (Hardy and Allsop, 1991; Hardy and Higgins, 1992) states that overproduction of Aβ, or failure to clear this peptide, leads to AD primarily through amyloid deposition, which triggers the production of NFT, cell death and, ultimately, the clinical symptoms such as memory loss and cognitive impairment (Hardy et al., 1998) .
Definitive diagnosis of AD relies on the demonstration of sufficient amounts of Aβ plaques and NFT in autopsy brains (Mirra et al., 1991) . Recently, the development of the PET tracer Pittsburgh Compound-B has made the in-vivo imaging of amyloid possible, with striking differences in PiB retention observed between control and AD subjects in brain areas known to contain significant amyloid deposits in AD (e.g., frontal cortex and parietal cortex) (Fig. 1) (Klunk et al., 2004) . Fluoro-2-deoxy-D-glucose (FDG) PET shows decreases in cerebral glucose metabolism, with a characteristic regional pattern of posterior temporoparietal N frontal hypometabolism in AD (Foster et al., 2007; Friedland et al., 1983; Herholz et al., 2007; Jagust et al., 2007) (Fig. 1) .
Imaging AD pathology, using amyloid PET imaging agents such as PiB, and imaging AD neurodegenerative processes, using FDG PET (as well other markers such as structural MRI and CSF tau), have several potential clinical benefits: early or perhaps preclinical detection of disease and accurately distinguishing AD from non-AD dementia in patients with mild or atypical symptoms or confounding comorbidities Neurobiology of Disease 72 (2014) 117-122 
